SLS Logo on CK Group website

Initial results of Salford Lung Study released

Salford Lung Study results show COPD patients treated with Relvar® Ellipta® achieve superior reduction in exacerbations compared with ‘usual care’  



Pioneering GSK study provides important new data on the effectiveness of Relvar Ellipta (FF/VI) when used in everyday clinical practice

The highly anticipated results from the Salford Lund Study were announced by GSK on 24th May 2016 ( Continue reading

Posted in Key MilestonesTagged in , , , , , , , , , , ,